TRACEY BARKER: Open Payments
NPI 1669817219 · RUSSELLVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$535 in 30 payments from 13 companies in 2025. Trend: 2023 $641 · 2024 $392 · 2025 $535
Food & beverage: $497Education: $38
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $142 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $91 |
| ABBVIE INC. | 2 | $47 |
| PFIZER INC. | 2 | $47 |
| Corcept Therapeutics | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $29 |
| Lundbeck LLC | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Dexcom, Inc. | 1 | $27 |
| Novo Nordisk Inc | 1 | $21 |
Products named: CAPLYTA, XIFAXAN, REXULTI, NURTEC ODT, Korlym, VOQUEZNA, Dexcom G6 Transmitter, QULIPTA.
Industry payments across KY — which companies pay providers there.
